Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
125.00    -1.40 (-1.11%)
Bid:
124.20
Ask:
125.20
Spread: 1.00 (0.805%)
Market Cap: £520.51m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Interim Results

27 Mar 2018 07:00

RNS Number : 8060I
James Halstead PLC
27 March 2018
Β 

Β 

27 March 2018

JAMES HALSTEAD PLC

Β 

INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2017

Β 

Key Figures

Β 

James Halstead plc, the AIM listed manufacturer and international distributor of commercial floor coverings, reports:

Β 

Β 

Β· Revenue higher at Β£126.0 million - an increase of 5.4%

Β 

Β· Operating profit higher at Β£23.9 million - an increase of 1.6%

Β 

Β· Pre-tax profit higher at Β£23.7 million - an increase of 2.0%

Β 

Β· Basic earnings per ordinary share 8.8p - a increase of 3.5%

Β 

Β· Interim dividend increased to a record 3.85p - an increase of 2.7%

Β 

Β· Net cash at Β£47.5 million

Β 

Β 

Β Β Β 

The Chief Executive, Mr. Mark Halstead, commented:

Β 

β€œYet another record half-year for sales and profit and once again an increase in dividend.”

Β 

Β 

Β 

Enquiries:

Β 

James Halstead

0161 767 2500

Mark Halstead, Chief Executive

Β 

Gordon Oliver, Finance Director

Β 

Β 

Β 

Hudson Sandler

020 7796 4133

Nick Lyon

Β 

Β 

Β 

Panmure Gordon (Nomad and Joint Broker)

020 7886 2500

Ben Thorne

Andrew Potts

Β 

Β 

Β 

Β 

Arden Partners (Joint Broker)

Chris Hardie

020 7614 5900

Β 

Β 

Β 

CHAIRMAN'S STATEMENT

Trading

Β 

In my first announcement as Chairman, I am greatly pleased to be able to continue the long tradition of reporting not only a record level of sales at the interim but more gratifyingly increased profit and an increased interim dividend.

Β 

Group turnover at Β£126.0 million (2016: Β£119.6million) was some 5.4% ahead. The mix and range of customers continues to be as diverse as it is global, whether it is the KitΓ©a Furniture stores across Morocco, the Tullibardine Whisky Distillery located in Perth & Kinross or the The University of Corsica founded by Pasquale Paoli in 1765. Our sales encompass new buildings, extensions and refurbishment. The UK turnover is one third of total sales and was some 2.6% ahead of the comparative period. Given the tumult in the facilities management sector, not least the demise of Carillion, this is to my mind, commendable. Objectflor, reported just over 2% growth in sales in local currency which is creditable against the strong competition. In sterling terms Europe overall fared well with 4.4% sales growth in Germany and just over 14% in France.

Β 

Our pre-tax profit at Β£ 23.7 million (2016: Β£23.2 million) is some 2% ahead of the prior year comparative and is creditable against the raw material cost increases in this six months' trading, some 13.9% ahead of the comparable period. We noted in our preliminary results (issued 2 October 2017) that we had commenced utilising bulk storage for raw materials in Teesside to more easily source raw materials from Asia. This has not only mitigated European shortages but has also led to lower raw material prices than those available from local sources. Up to 50% of our polymer requirements are sourced this wayΒ and are a hedge against pricing / exchange rate issues with European supply. In addition, we can offset customs import duty as around 25% of our exports are outside the EU customs area.

Β 

One of the many positives in this trading period is that our sales in Australia have grown 7%. Having moved our Queensland warehouse to larger premises, opened our first warehouse in South Australia and augmented our sales force with representatives in Far North Queensland and Tasmania, the business continues to drive bottom line growth.

Β 

I am pleased to report that continued investment in sales representation at Polyflor Canada Inc. is bearing fruit with over a 25% increase in turnover in the period. Falck Design, based in Sweden, posted 9% growth. Polyflor India, having made a good start last year, has slipped backward with a decline in sales that resulted from the introduction of general sales tax (GST) in July 2017 which disrupted construction activity and purchasing particularly in our core healthcare sector. Current trading is now back up at prior year levels and growing. Our sales in the Middle East have also more than doubled with numerous healthcare and education sector projects completing together with projects in Qatar such as the Al Bayt and Khalifa Stadiums.

Β 

The Company will soon reach another milestone in its history- seventy years as a publicly quoted company. James Halstead floated on the LSE on 4th May 1948. At float there were 700,000 shares of 10 shillings in issue and anyone who followed the buy advice of W I Carr (stockbrokers) in November 1948 would have seen an approximate 300,000% return on their investment (not including dividends). One month after our flotation, one of our major customers of today also came into being- the National Health Service. These days our healthcare sales extend far and wide from Mediclinic Dubai, to Guizhou Provincial Cancer Hospital in China.

Β 

In addition to healthcare, our presence in retail continues to expand with global partners such as Montblanc stores (globally), Marc Dorcel stores across France, Thalia book stores across Germany and Freshii restaurants in Canada. Further examples of the breadth of applications of our flooring are the Indian Space Research Organisation (ISRO) semi-conductor laboratories, in Dehli, the Universal Church of San Paolo in Brazil and Central Bark dog hotel in Auckland.

Β 

We continue to focus on customer service to maintain market penetration and to be industry leaders, for example in responsible sourcing. BES6001 certification is the "gold" standard for the responsible sourcing of construction products and in recent months Polyflor was awarded an "excellent" rating by the independent certifying body. We continue to trail blaze in our approach to PVC waste collection and recycling and Polyflor are proud to announceΒ the 8th annual Recofloor Awards event, which will soon take place at Anfield Football Stadium, hosted by footballing legend Kevin Keegan.

Β 

Earnings per Share

Β 

Our basic earnings per share at 8.8p are above the comparative period of 8.5p by 3.5%.

Β 

Having regard to cash, which stands at Β£47.5 million, I am pleased to say that an interim dividend of 3.85p has been declared (2017: 3.75p), representing a 2.7% increase and this reflects both the strength of earnings and the cash reserves of the Company. This will be payable on 6 June 2018 to those shareholders on the register at the close of business on 4 May 2018.

Β 

Outlook

Β 

The three months leading up to the half-year end saw us preparing for range updates and new product launches at the major European exhibitions held in January and February and I am pleased to report an encouragingly strong reception for these which should underpin the second half of the year.

Β 

We noted in our pre-close trading update (29 January 2018) that a German competitor had entered administration and would be closing its resilient vinyl manufacturing facility and this has now happened.Β Β In consequence we have received multiple enquires from customers of that business. To date, we have converted many of these enquiries into sales across the European market and more will follow.

Β 

Looking at the period since the half-year it is pleasing to note that January trading was a particularly strong sales month and February and March also compared well to last year such that, to date, sales are ahead of the comparative by some 10%.

Β 

Against this background I have confidence in continued progress.

Β 

Β 

Anthony Wild

Chairman

27 March 2018

Β 

Consolidated Income Statement

for the half-year ended 31 December 2017

Β 

Β 

Β 

Half-yearΒ 

endedΒ 

31.12.17Β 

Β£'000Β 

Β 

Half-yearΒ 

endedΒ 

31.12.16Β 

Β£'000Β 

Β 

YearΒ 

endedΒ 

30.06.17Β 

Β£'000Β 

Β 

Β 

Β 

Β 

Revenue

126,024Β 

119,558Β 

240,784Β 

Β 

Β 

Β 

Β 

Operating profit

23,914Β 

23,532Β 

47,284Β 

Net finance cost

(229)

(311)

(668)

Β 

Β 

Β 

Β 

Profit before income tax

23,685Β 

23,221Β 

46,616Β 

Β 

Β 

Β 

Β 

Income tax expense

(5,292)

(5,533)

(10,106)

Β 

Β 

Β 

Β 

Profit for the period

18,393Β 

17,688Β 

36,510Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Earnings per ordinary share of 5p:

Β 

Β 

Β 

-basic

8.8p

8.5p

17.6p

-diluted

8.8p

8.5p

17.6p

Β 

Β 

Β 

Β 

Β 

Β 

Β 

All amounts relate to continuing operations.

Β 

Details of dividends paid and declared/proposed are given in note 4.

Β 

Β 

Β 

Consolidated Balance Sheet

as at 31 December 2017

Β 

Β 

Half-year

ended

31.12.17

Β£'000

Half-year

ended

31.12.16

Β£'000

Year

ended

30.06.17

Β£'000

Non-current assets

Β 

Β 

Β 

Property, plant and equipment

36,539Β 

35,176Β 

36,103Β 

Intangible assets

3,232Β 

3,232Β 

3,232Β 

Deferred tax assets

3,394Β 

5,704Β 

4,151Β 

Β 

43,165Β 

44,112Β 

43,486Β 

Current assets

Β 

Β 

Β 

Inventories

73,831Β 

61,948Β 

72,936Β 

Trade and other receivables

26,630Β 

24,851Β 

31,176Β 

Derivative financial instruments

384Β 

1,670Β 

416Β 

Cash and cash equivalents

47,483Β 

51,607Β 

52,532Β 

Β 

148,328Β 

140,076Β 

157,060Β 

Β 

Β 

Β 

Β 

Total assets

191,493Β 

184,188Β 

200,546Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Trade and other payables

51,412Β 

51,361Β 

59,321Β 

Derivative financial instruments

1,434Β 

636Β 

1,362Β 

Current income tax liabilities

4,775Β 

5,287Β 

3,860Β 

Β 

57,621Β 

57,284Β 

64,543Β 

Β 

Β 

Β 

Β 

Non-current liabilities

Β 

Β 

Β 

Retirement benefit obligations

16,532Β 

28,127Β 

21,257Β 

Deferred tax liabilities

-

603Β 

-

Borrowings

200Β 

200Β 

200Β 

Other payables

479Β 

476Β 

486Β 

Β 

17,211Β 

29,406Β 

21,943Β 

Β 

Β 

Β 

Β 

Total liabilities

74,832Β 

86,690Β 

86,486Β 

Β 

Β 

Β 

Β 

Net assets

116,661Β 

97,498Β 

114,060Β 

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Equity share capital

10,399Β 

10,381Β 

10,393Β 

Equity share capital (B shares)

160Β 

160Β 

160Β 

Β 

10,559Β 

10,541Β 

10,553Β 

Share premium account

3,805Β 

3,256Β 

3,615Β 

Capital redemption reserve

1,174Β 

1,174Β 

1,174Β 

Currency translation reserve

6,021Β 

5,472Β 

6,194Β 

Hedging reserve

(186)

530Β 

(289)

Retained earnings

95,288Β 

76,525Β 

92,813Β 

Total equity attributable to shareholders of the parent

116,661Β 

97,498Β 

114,060Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated Cash Flow Statement

for the half-year ended 31 December 2017

Β 

Β 

Half-yearΒ 

endedΒ 

31.12.17Β 

Β£'000Β 

Half-yearΒ 

endedΒ 

31.12.16Β 

Β£'000Β 

YearΒ 

endedΒ 

30.06.17Β 

Β£'000Β 

Β 

Β 

Β 

Β 

Cash inflow from operations

20,211Β 

31,194Β 

47,478Β 

Net interest received

51Β 

81Β 

101Β 

Taxation paid

(4,337)

(4,548)

(10,682)

Β 

Β 

Β 

Β 

Cash inflow from operating activities

15,925Β 

26,727Β 

36,897Β 

Β 

Β 

Β 

Β 

Purchase of property, plant and equipment

(2,026)

(2,141)

(4,234)

Proceeds from disposal of property, plant and equipment

111Β 

82Β 

234Β 

Cash outflow from investing activities

(1,915)

(2,059)

(4,000)

Β 

Β 

Β 

Β 

Equity dividends paid

(19,238)

(17,646)

(25,438)

Shares issued

196Β 

167Β 

538Β 

Cash outflow from financing activities

(19,042)

(17,479)

(24,900)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net (decrease)/ increase in cash and cash equivalents

(5,032)

7,189Β 

7,997Β 

Effect of exchange differences

(17)

322Β 

439Β 

Cash and cash equivalents at start of period

52,532Β 

44,096Β 

44,096Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at end of period

47,483Β 

51,607Β 

52,532Β 

Β 

Β 

Consolidated Statement of Comprehensive Income

for the half-year ended 31 December 2017

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Half-yearΒ 

endedΒ 

31.12.17Β 

Β£'000Β 

Β 

Half-yearΒ 

endedΒ 

31.12.16Β 

Β£'000Β 

Β 

YearΒ 

endedΒ 

30.06.17Β 

Β£'000Β 

Β 

Profit for the period

18,393Β 

17,688Β 

36,510Β 

Β 

Other comprehensive income net of tax:

Β 

Β 

Β 

Re-measurement of the net defined benefit liability

3,317Β 

(2,853)

2,404Β 

Foreign currency translation differences

(173)

1,446Β 

2,168Β 

Fair value movements on hedging instruments

103Β 

1,229Β 

410Β 

Β 

Β 

Β 

Β 

Other comprehensive income for the period net of tax

Β 

3,247Β 

Β 

(178)

4,982Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

21,640Β 

17,510Β 

41,492Β 

Β 

Β 

Β 

Β 

Attributable to equity holders of the

Β 

Β 

Β 

parent

21,640Β 

17,510Β 

41,492Β 

Β 

Β 

Β 

Β 

Β 

Notes to the Interim Results

for the half-year ended 31 December 2017

Β 

1.

Basis of preparation

Β 

Β 

The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 2006.

Β 

The principal accounting policies applied in the preparation of the consolidated interim statements are those set out in the annual report and accounts for the year ended 30 June 2017.

Β 

The figures for the year ended 30 June 2017 are an abridged statement of the group audited accounts for that year. The financial statements for the year ended 30 June 2017 were audited and have been delivered to the Registrar of Companies.

Β 

As is permitted by the AIM rules, the directors have not adopted the requirements of IAS34 'Interim Financial Reporting' in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.

Β 

Β 

2.

Taxation

Β 

Β 

Income tax has been provided at the rate of 22.3% (2016: 23.8%).

Β 

Β 

3.

Earnings per share

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Half-year

ended

31.12.17

Β£'000

Β 

Half-year

ended

31.12.16

Β£'000

Β 

Year

ended

30.06.17

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

18,393

17,688

36,510

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Weighted average number of shares in issue

207,957,907

207,544,288

207,620,432

Β 

Β 

Dilution effect of outstanding share options

124,938

381,936

216,506

Β 

Β 

Diluted weighted average number shares

208,082,845

207,926,224

207,836,938

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Basic earnings per 5p ordinary share

8.8p

8.5p

17.6p

Β 

Β 

Diluted earnings per 5p ordinary share

8.8p

8.5p

17.6p

Β 

Β 

Β 

4.

Dividends

Β 

Β 

Β 

Β 

Β 

Half-year

ended

31.12.17

Β£'000

Half-year

ended

31.12.16

Β£'000

Year

ended

30.06.17

Β£'000

Β 

Equity dividends paid:

Β 

Β 

Β 

Β 

Β 

Final dividend for the year ended 30 June 2016

-

17,646

17,646

Β 

Interim dividend for the year ended 30 June 2017

-

-

7,792

Β 

Final dividend for the year ended 30 June 2017

19,238

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

19,238

17,646

25,438

Β 

Β 

Β 

Β 

Β 

Β 

Equity dividends declared/proposed at the end of the period

Β 

Β 

Β 

Β 

Interim dividend

8,007

7,792

-

Β 

Final dividend

-

-

19,238

Β 

Β 

Equity dividends per share, paid and declared/proposed are as follows:

Β 

Β 

8.5p final dividend for the year ended 30 June 2016, paid on 2 December 2016

3.75p interim dividend for the year ended 30 June 2017, paid on 6 June 2017

9.25p final dividend for the year ended 30 June 2017, paid on 1 December 2017

3.85p interim dividend for the year ended 30 June 2018, payable on 6 June 2018, to those shareholders on the register at the close of business on 4 May 2018

Β 

Β 

Β 

Β 

5.

Β 

Β 

Copies of the interim results

Β 

Β 

Copies of the interim results have been sent to shareholders who requested them. Further copies can be obtained from the Company's registered office, Beechfield, Hollinhurst Road, Radcliffe, Manchester, M26 1JN and on the Company's website - www.jameshalstead.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR SEWFLDFASEED
Date   Source Headline
9th Apr 20265:32 pmRNSGrant of Options
8th Apr 20265:19 pmRNSHolding(s) in Company
31st Mar 20267:00 amRNSInterim Results
23rd Feb 20264:48 pmRNSPDMR Acquisition of Shares
30th Jan 20263:32 pmRNSShare Buyback - Replacement
30th Jan 20262:44 pmRNSShare Buyback
29th Jan 20267:00 amRNSTrading Update
8th Jan 20268:20 amRNSBlock Listing Six Monthly Return
5th Dec 20251:00 pmRNSResult of AGM
5th Dec 20257:00 amRNSChairman’s Statement to the Annual General Meeting
14th Nov 202512:12 pmRNSDirector/PDMR Shareholding
14th Nov 202512:11 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSPosting of Annual Report and Notice of AGM
1st Oct 20257:00 amRNSPreliminary Results
8th Sep 20257:00 amRNSNotice of Preliminary Results
29th Aug 20253:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSTrading Update
9th Apr 20255:32 pmRNSHolding(s) in Company
7th Apr 202512:25 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSInterim Results
6th Mar 202510:41 amRNSNotice of Interim Results - Replacement
6th Mar 20259:00 amRNSNotice of Inteirm Results
6th Mar 20257:00 amRNSNotice of Interim Results
31st Jan 20257:00 amRNSTrading Update and Notice of Results
27th Jan 20255:09 pmRNSDirector/PDMR Shareholding
6th Jan 20253:15 pmRNSBlock Listing Six Monthly Return
6th Dec 20242:09 pmRNSResults of AGM
6th Dec 20247:00 amRNSAGM Statement
18th Oct 20249:20 amRNSPosting of Annual R&A and Notice of AGM
1st Oct 20247:00 amRNSBoard Changes
1st Oct 20247:00 amRNSPreliminary Results
7th Aug 20248:05 amRNSBlock Listing Six Monthly Return
31st Jul 20247:00 amRNSTrading Update
15th Jul 20247:00 amRNSChange of Broker
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.